Cynata Therapeutics Ltd
F:51S
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
F:51S
|
AU |
|
E
|
Eagle High Plantations Tbk PT
XMUN:7B7
|
ID |
|
M
|
Montego Resources Inc
OTC:MONGF
|
CA |
|
P
|
Pan African Resources PLC
OTC:PAFRY
|
UK |
|
Lomiko Metals Inc
F:DH8C
|
CA |
|
N
|
NFI Group Inc
F:9NF
|
CA |
|
Toei Animation Co Ltd
OTC:TOEAF
|
JP |
|
C
|
Copper Road Resources Inc
OTC:STGDF
|
CA |
|
Z
|
Zignago Vetro SpA
SWB:ZVB
|
IT |
|
O
|
Odyssee Technologies SA
F:V4Y
|
FR |
|
Orange Polska SA
OTC:PTTWF
|
PL |
|
Marinomed Biotech AG
F:MBG
|
AT |
|
Rocca SA
F:82J
|
PL |
Bankruptcy Probability
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cynata Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AU |
|
Cynata Therapeutics Ltd
ASX:CYP
|
2.8m AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
233.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
136.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
56.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cynata Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cynata Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
